Agsalona, Maverick B.
HRN: 27-48-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2025
CEFUROXIME 750MG (VIAL)
07/17/2025
07/24/2025
IV
750mg
Q8
Surgical Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes